Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
15.01
+0.01 (0.03%)
Aug 15, 2025, 10:30 AM - Market open

Oruka Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024
Period Ending
Aug '25 Dec '24
Market Capitalization
562679
Enterprise Value
213325
Last Close Price
15.0019.39
PB Ratio
1.651.78
P/TBV Ratio
1.651.79
Debt / Equity Ratio
0.010.00
Quick Ratio
27.1228.80
Current Ratio
27.4228.89
Earnings Yield
-13.78%-13.46%
FCF Yield
-17.12%-9.33%
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q